News

News Articles

1. Interviews, The Economist

   17, Apr, 2024

   CEO Matt Cheng dis­cuss­es the micro­bio­me on The Econ­o­mist’s Bab­bage podcast

2. Interviews, Kanvas Bio

   15, Mar, 2024

   End­points News’ Ven­ture Invest­ing in Biotech Webi­nar Got Us Fired Up

3. External news, MedCity News

   29, Feb, 2024

   It’s Time to Evolve Beyond FMTs and Advance LBPs

4. Interviews, Kanvas Bio

   26, Jan, 2024

   Kan­vas Bio’s State of the Art AI Mod­els & Reflec­tions from JPM 2024

5. Interviews, Kanvas Bio

   19, Dec, 2023

   Kan­vas Bio Annu­al Sci­ence Day Recap

6. External news, DCVC

   11, Oct, 2023

   With Assets from Fed­er­a­tion Bio, Kan­vas Aims to Replace Impre­cise Micro­bio­me Ther­a­pies with a Sin­gle, Ratio­nal­ly Designed Pill

7. External news, Fierce Biotech

   11, Oct, 2023

   As Fed­er­a­tion folds, Kan­vas Bio Picks Up the Pieces to Become Clin­i­cal-Stage Company

8. Press releases, Kanvas Bio

   11, Oct, 2023

   Kan­vas Bio­sciences Acquires Fed­er­a­tion Bio Assets

9. External news, DCVC

   22, Jun, 2023

   DCVC Leads $12M Financ­ing for Kan­vas Bio­sciences to Map the Human Body’s Undis­cov­ered Ter­ri­to­ry: The Microbiome

10. Press releases, PR Newswire

    22, Jun, 2023

    Kan­vas Clos­es $12M Fund­ing Round